189 related articles for article (PubMed ID: 19180099)
1. Trial watch: Phase III promise for oral multiple sclerosis therapy.
Nat Rev Drug Discov; 2009 Feb; 8(2):98. PubMed ID: 19180099
[No Abstract] [Full Text] [Related]
2. Multiple sclerosis: closing in on an oral treatment.
Martin R
Nature; 2010 Mar; 464(7287):360-2. PubMed ID: 20237554
[No Abstract] [Full Text] [Related]
3. Oral fingolimod (gilenya) for multiple sclerosis.
Med Lett Drugs Ther; 2010 Dec; 52(1353-1354):98-9. PubMed ID: 21344782
[No Abstract] [Full Text] [Related]
4. [FTY720 (Fingolimod) as a new therapeutic option for multiple sclerosis].
Klatt J; Hartung HP; Hohlfeld R
Nervenarzt; 2007 Oct; 78(10):1200-8. PubMed ID: 17668161
[TBL] [Abstract][Full Text] [Related]
5. [A plan for risk management in the treatment of multiple sclerosis with gilenia (fingolimod)].
Popova NF
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(2 Pt 2):110-3. PubMed ID: 21916166
[No Abstract] [Full Text] [Related]
6. [New, effective immunomodulatory drug in treatment of multiple sclerosis: the fingolimod].
Komoly S
Ideggyogy Sz; 2012 Nov; 65(11-12):421-2. PubMed ID: 23289178
[No Abstract] [Full Text] [Related]
7. Novartis eyes oral MS drug as potential blockbuster.
Ratner M
Nat Biotechnol; 2010 Nov; 28(11):1135-6. PubMed ID: 21057464
[No Abstract] [Full Text] [Related]
8. Ventricular tachycardia on chronic fingolimod treatment for multiple sclerosis.
Castillo-Trivino T; Lopetegui I; Alarcón-Duque JA; López de Munain A; Olascoaga J
J Neurol Neurosurg Psychiatry; 2015 Aug; 86(8):931-2. PubMed ID: 25835036
[No Abstract] [Full Text] [Related]
9. New drugs may improve, complicate treatment for multiple sclerosis.
Link H; Martin R
Nat Med; 2010 Mar; 16(3):272. PubMed ID: 20208513
[No Abstract] [Full Text] [Related]
10. FTY720 and central memory: out of sight, out of mind.
Slavin AJ; Zamvil SS
Neurology; 2010 Aug; 75(5):388-9. PubMed ID: 20610831
[No Abstract] [Full Text] [Related]
11. Overview and safety of fingolimod hydrochloride use in patients with multiple sclerosis.
Ward MD; Jones DE; Goldman MD
Expert Opin Drug Saf; 2014 Jul; 13(7):989-98. PubMed ID: 24935480
[TBL] [Abstract][Full Text] [Related]
12. Fingolimod-associated amenorrhea: a report of three cases.
Alroughani R
Mult Scler; 2014 Oct; 20(12):1662-4. PubMed ID: 24515730
[TBL] [Abstract][Full Text] [Related]
13. Fingolimod for the treatment of relapsing multiple sclerosis.
Jeffery DR; Markowitz CE; Reder AT; Weinstock-Guttman B; Tobias K
Expert Rev Neurother; 2011 Feb; 11(2):165-83. PubMed ID: 21158700
[TBL] [Abstract][Full Text] [Related]
14. Fingolimod and multiple sclerosis: four cautionary tales.
Bourdette D; Gilden D
Neurology; 2012 Nov; 79(19):1942-3. PubMed ID: 23035058
[No Abstract] [Full Text] [Related]
15. Fingolimod for multiple sclerosis.
Pelletier D; Hafler DA
N Engl J Med; 2012 Jan; 366(4):339-47. PubMed ID: 22276823
[No Abstract] [Full Text] [Related]
16. Fingolimod: cardiovascular deaths.
Prescrire Int; 2012 Apr; 21(126):99. PubMed ID: 22515137
[No Abstract] [Full Text] [Related]
17. Fingolimod-induced atrioventricular conduction defects in a young lady with multiple sclerosis--insights into possible drug mechanism.
Voon V; Saiva L; O'Kelly S; Keane D
Eur J Clin Pharmacol; 2014 Mar; 70(3):373-5. PubMed ID: 24309839
[No Abstract] [Full Text] [Related]
18. A randomized, controlled trial of fingolimod (FTY720) in Japanese patients with multiple sclerosis.
Saida T; Kikuchi S; Itoyama Y; Hao Q; Kurosawa T; Nagato K; Tang D; Zhang-Auberson L; Kira J
Mult Scler; 2012 Sep; 18(9):1269-77. PubMed ID: 22354739
[TBL] [Abstract][Full Text] [Related]
19. Drugs: An injection of hope.
Graham-Rowe D
Nature; 2012 Apr; 484(7393):S4. PubMed ID: 22509505
[No Abstract] [Full Text] [Related]
20. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.
Kappos L; Radue EW; O'Connor P; Polman C; Hohlfeld R; Calabresi P; Selmaj K; Agoropoulou C; Leyk M; Zhang-Auberson L; Burtin P;
N Engl J Med; 2010 Feb; 362(5):387-401. PubMed ID: 20089952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
